Daily Briefing · 2026-09-29

In the semiconductor space, TSMC's 2 nanometer process is ramping into high-gear production, setting the chipmaker up to capture a larger share of next-generation demand. Arcosa delivered stronger quarterly earnings, but investors are now more focused on how its transformative CRH acquisition will reshape the company going forward. Novo Nordisk shares have fallen more than seventy percent from their peak, and some investors now see that pullback as an attractive entry point given its leading GLP-1 franchise. In energy, Canadian Natural Resources is being highlighted as a top pick among diversified producers, positioned to benefit from steady oil demand despite market volatility. Japanese retailer Shimamura posted a two point three percent drop in quarterly revenue, with operating profit down nearly sixteen percent amid rising competition and inventory adjustments. On the biotech front, Invivyd reported positive Phase three topline data for its antibody candidate VYD2311, setting the stage for a regulatory submission. In the UK, Card Factory is facing earnings pressure this quarter as store closures and restructuring costs weigh on profitability. Market strategists are warning that rising bond yields could pressure stock valuations and limit further equity gains built on low-rate assumptions. On the personal finance side, new credit card users are commonly losing money by not maximizing rewards relative to annual fees, according to a new points-focused analysis. In China, an A-shares tracking fund touched a one-year low, raising fresh questions about the near-term direction of Chinese equities. And in aerospace, the eVTOL certification race between Joby and Archer is shifting focus away from who certifies first toward longer-term competitive positioning.